These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rap1 and its regulatory proteins: the tumor suppressor, oncogene, tumor suppressor gene axis in head and neck cancer. Banerjee R; Russo N; Liu M; Van Tubergen E; D'Silva NJ Small GTPases; 2012; 3(3):192-7. PubMed ID: 22684501 [TBL] [Abstract][Full Text] [Related]
3. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648 [TBL] [Abstract][Full Text] [Related]
4. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599 [TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778 [TBL] [Abstract][Full Text] [Related]
6. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma. Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer. Chen H; Tu SW; Hsieh JT J Biol Chem; 2005 Jun; 280(23):22437-44. PubMed ID: 15817459 [TBL] [Abstract][Full Text] [Related]
8. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Varambally S; Cao Q; Mani RS; Shankar S; Wang X; Ateeq B; Laxman B; Cao X; Jing X; Ramnarayanan K; Brenner JC; Yu J; Kim JH; Han B; Tan P; Kumar-Sinha C; Lonigro RJ; Palanisamy N; Maher CA; Chinnaiyan AM Science; 2008 Dec; 322(5908):1695-9. PubMed ID: 19008416 [TBL] [Abstract][Full Text] [Related]
9. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers. Au SL; Wong CC; Lee JM; Wong CM; Ng IO PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380 [TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Fiskus W; Pranpat M; Balasis M; Herger B; Rao R; Chinnaiyan A; Atadja P; Bhalla K Mol Cancer Ther; 2006 Dec; 5(12):3096-104. PubMed ID: 17172412 [TBL] [Abstract][Full Text] [Related]
11. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma. Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643 [TBL] [Abstract][Full Text] [Related]
12. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma. Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926 [TBL] [Abstract][Full Text] [Related]
13. The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2. Beke L; Nuytten M; Van Eynde A; Beullens M; Bollen M Oncogene; 2007 Jul; 26(31):4590-5. PubMed ID: 17237810 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the histone methyltransferase EZH2 contributes to the epigenetic programming of decidualizing human endometrial stromal cells. Grimaldi G; Christian M; Steel JH; Henriet P; Poutanen M; Brosens JJ Mol Endocrinol; 2011 Nov; 25(11):1892-903. PubMed ID: 21903722 [TBL] [Abstract][Full Text] [Related]
16. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591 [TBL] [Abstract][Full Text] [Related]
17. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029 [TBL] [Abstract][Full Text] [Related]
18. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826 [TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Fujii S; Ochiai A Cancer Sci; 2008 Apr; 99(4):738-46. PubMed ID: 18377425 [TBL] [Abstract][Full Text] [Related]
20. The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Babbio F; Pistore C; Curti L; Castiglioni I; Kunderfranco P; Brino L; Oudet P; Seiler R; Thalman GN; Roggero E; Sarti M; Pinton S; Mello-Grand M; Chiorino G; Catapano CV; Carbone GM; Bonapace IM Oncogene; 2012 Nov; 31(46):4878-87. PubMed ID: 22330138 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]